This MSF report examines the barriers to accessing new drug-resistant tuberculosis (DR-TB) treatments, highlighting pricing, registration, and policy gaps.
Other
Ready, Set, Slow down: New and promising DR-TB drugs are grabbing headlines but not reaching patients
Publication Date:
2014
Share Article
Related Publications
Search All Publications
Browse the full Publication Library — filter by impact area, resource type, year and collection to find what you need.